Adenosine receptors in the cardiovascular system

Drug Development Research

Volumn 39, Issue 3-4, 1996, Pages 301-307

  Olsson, Ray A ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Box 19 ^*  (United States)

Author keywords

Adenosine receptors; Angina pectoris; Endothelial permeability; Ischemic preconditioning; Nitric oxide; Potassium channels

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; NITRIC OXIDE; POTASSIUM CHANNEL;

ANGINA PECTORIS; CAPILLARY PERMEABILITY; CARDIOVASCULAR SYSTEM; CONFERENCE PAPER; ENDOTHELIUM CELL; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN;

EID: 0030428258     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199611/12)39:3/4<301::AID-DDR9>3.0.CO;2-V     Document Type: Conference Paper

References (83)

1. Abebe W, Hussain T, Olanrewaju H, Mustafa SJ (1995): Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery. Am J Physiol 269:111672-111678.
2. Abreu A, Mahmarian JJ, Nishumura S, Boyce TM, Verani MS (1991): Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol 18:730-735.
3. 1 adenosine receptors. J Biochem 117:183-189.
4. ATP channels, and ischemic preconditioning in dogs. Am J Physiol 264:1327-111334.
5. Balligand J-L, Kelly RA, Marsden PA, Smith TW, Michel T (1993): Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 90:347-351.
6. Belardinelli L, Shryock JC, Song Y, Wang D, Srinivas M (1995): Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J 9:359-365.
7. Bertolet BD, Belardinelli L, Hill JA (1993): Absence of adenosine-induced chest pain after total cardiac afferent denervation. Am J Cardiol 72:483-484.
8. 1 adenosine receptor-mediated effects in humans. Circulation 93:1871-1876.
9. 21, adenosine receptor in NIH 3T3 fibroblasts. Biochem Pharmacol 47:801-814.
10. Bredt DS, Ferris CD, Snyder SH (1992): Nitric oxide regulatory sites: Phosphorylation by cyclic AMP dependent protein kinase. protein kinasc C and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem 267:10976-10981.
11. Brüne B, Lapetina EG (1991): Phosphorylation of nitric oxide synthase by protein kinase A. Biochem Biophys Res Commun 181:921-926.
12. Buga CM, Gold ME, Fukuto JM, Ignarro LJ (1991): Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17:187-193.
13. Crea F, Pupita C, Galassi AR, el-Tumimi H, Kaski JC, Davies C, Maseri A (1990): Role of adenosine in pathogenesis of anginal pain. Circulation 81:164-172.
14. Daut J, Maier-Rndolph W, von Beckerath N, Mehrke G, Günther K, Goedel-Meinen L (1990): Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247:1341-1344.
15. Dinerman JL, Steiner JP, Dawson TM, Dawson V, Snyder SH (1994): Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology 33:1245-1251.
16. Drury AN, Szent-Györgyi A (1929): The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68:213-237.
17. Du XY, Schoemaker RG, Bos E, Saxena PR (1994): Different pharmacological responses of atrium and ventricle: Studies with human cardiac tissue. Eur J Pharmacol 259:173-180.
18. Fox AC, Reed GE, Classman E, Kaltman AJ, Silk BB (1974): Release of adenosine from human hearts during angina induced by rapid atrial pacing. J Clin Invest 53:1447-1457.
19. 3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br J Pharmacol 109:3-5.
20. 3 receptor activation in rats. Eur J Pharmacol 298:293-297.
21. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM (1995): Role of brandykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77:611-621.
22. Gurden MF, Coates J, Ellis F, Evans B, Foster M, Hornby E, Kennedy I, Martin DP, Strong P, Vardey CJ, Wheeldon A (1993): Functional characterization of three adenosine receptor types. Br J Pharmacol 109:693-698.
23. Hamilton HW, Taylor MD, Steffen RP, Haleen SJ, Bruns RF (1987): Correlation of adenosine receptor affinities and cardiovascular activity. Life Sci 41:2295-2302.
24. Han X, Shimoni Y, Giles WR (1994a): A cellular mechanism for nitric oxide-mediated cholinergic modulation of heart rate. J Physiol 480P
25. Han X, Shimoni Y, Giles WR (1994b): An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J Physiol 476:309-314.
26. 3 receptor-mediated hypotension in the rat. Br J Pharmacol 115:945-952.
27. 1AR stimulation activates δ-protein kinase C in rat ventricular myocytes. Circ Res 78:161-165.
28. + channels in cerebral ischemic conditioning. Proc Natl Acad Sci USA 92:4666-4670.
29. Hirata K-I, Kurodu R, Sakoda T, Katayama M, Inoue N, Suematsu M, Kawashima S, Yokoyama M (1995): Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25:180-185.
30. 1B adrenoceptors, pertussis toxin-sensitive G proteins and protein kinase C. Circulation 92:2259-2265.
31. 3]8-cyclopentyl-1,3-dipropylxanthine in coronary smooth muscle. Circ Res 77:194-198.
32. + channel in guinea pig atrial cell membrane. J Gen Physiol 99:961-983.
33. 2 receptor-cAMP system in human aortic endothelial cells. Biochem Biophys Res Commun 199:905-910.
34. Jones CJH, Kuo L, Davis MJ, DeFily DV, Chillian WM (1995): Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation 91:1807-1813.
35. Karczewski P, Bartel S, Krause EG (1993): Protein phosphorylation in the regulation of cardiac contractility and vascular smooth muscle tone. Curr Opin Nephrol Hypertens 2:33-40.
36. 2A receptor antagonist. Eur J Pharmacol 301:107-113.
37. + channels to A1AR receptors by G proteins in rat ventricular myocytes. Am J Physiol 259:H820-H826.
38. 2 receptors and cAMP-dependent protein kinase. Proc Natl Acad Sci USA 92:12441-12445.
39. Lagerqvist B, Sylven C, Helmius G, Waldenstrom A (1990): Effects of exogenous adenosine in a patient with transplanted heart. Evidence for adenosine as a messenger in angina pectoris. Ups J Med Sci 95:137-145.
40. Ca by carbachol and sodium nitroprusside. Pflügers Arch 426:419-426.
41. Li G-R, Feng J, Shrier, Nattel S (1995): Contribution of ATP-sensitive potassium channels to the electrophysiological effects of adenosine in guinea-pig atrial cells. J Physiol 484:629-642.
42. Li J-M, Kenton RA, Cutler BB, Dobson JG Jr (1995): Adenosine enhances nitric oxide production by vascular endothelial cells. Am J Physiol 269:C519-C523.
43. 2b, receptors in cultured fetal chick heart cells. High-and low-affinity coupling to Stimulation of myocyte contractility and cAMP accumulation. Circ Res 76:242-251.
44. Lin Y, Ytrehus K, Downey JM (1994): Evidence that translocation of protein kinase C is a key event during ischemic preconditioning. J Mol Cell Cardiol 26:661-668.
45. Liu Y, Tsuchida A, Cohen MV, Downey JM (1995): Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 27:883-892.
46. 2b receptors in the guinea pig aorta. Eur J Pharmacol 216:235-242.
47. 2 adenosine receptors in the aorta and coronary vessels Iron) the guinea pig. J Pharmacol Exp Ther 265:248-253.
48. Martynyuk AE, Kane KA, Cobbe SM, Rankin AC (1996): Nitric oxide mediates the anti-adrenergic effect of adenosine on calcium current in isolated rabbit atrioventricular nodal cells. Pflügers Arch 431:452-457.
49. Merkel LA, Lappe RW, Rivera LM, Cox LM, Perrone MH (1992): Demonstration of vasorelaxant activity with an A1-selcctivc adenosine agonist in porcine coronary artery: Involvement of potassium channels. J Pharmacol Exp Ther 260:437-443.
50. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 88:1197-1201.
51. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268:26286-26295.
52. 2 receptor activity. Biochem Biophys Res Commun 168:1297-1302.
53. Murry CE, Jennings RE, Reimer KA (1986): Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136.
54. Nunain SO, Garratt C, Paul V, Debbas N, Ward DE, Camm AJ (1992): Effect of intravenous adenosine on human atrial and ventricular repolarization. Cardiovase Res 26:939-943.
55. Ohara V, Sayegh HS, Yamin JJ, Harrison DG (1995): Regulation of eudothelial constitutive nitric oxide synthase by protein kinase C. Hypertension 25:415-420.
56. 2+ current in guinea-pig ventricular cells. J Physiol 443:387-404.
57. Ovize M, Kloner RA, Przyklenk K (1994): Stretch preconditions canine myocardium. Am J Physiol 266:H137-H146.
58. Pang CY, Forrest CR (1995): Acute pharmacologic preconditioning as a new concept and alternative approach for prevention of skeletal muscle ischemic necrosis. Biochem Pharmacol 49:1023-1034.
59. Patton WF, Alexander JS, Dodge AB, Patton RJ, Hechtman HB, Shepro D (1991): Mercury-arc photolysis: A method for examining second messenger regulation of endothelial cell monolayer integrity. Anal Biochem 196:31-38.
60. 2a adenosine receptor subtype in functional hyperaemia in the hindlimb of anaesthetized cats. J Physiol 492:495-503.
61. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO III (1995): Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 92:320-326.
62. Romano FD, Macdonald SG, Dobson JG Jr (1989): Adenosine recep-tor coupling to adenylate cyclase of rat ventricular myocyte membranes. Am J Physiol 257:H1088-H1095.
63. Rubanyi CM, Romero JC, Vanhoutte PM (1986): Flow-induced release of endothelium-dependent relaxing factor. Am J Physiol 250:H1145-H1149.
64. Schiele JO, Schwabe U (1994): Characterization of the adenosine receptor in microvascular coronary endothelial cells. Eur J Pharmacol 269:51-58.
65. Schrader J, Baumann G, Gerlach E (1977): Adenosine as inhibitor of myocardial effects of catecholamines. Pflügers Arch 372:29-35.
66. Schultz JE, Rose E, Yao Z, Gross GJ (1995): Evidence for the involvement of opioid receptors in ischemic preconditioning. Am J Physiol 268:H2157-H2161.
67. 2-adenosine receptor agonists do not alter action potential duration, twitch shortening, or cAMP accumulation in guinea pig, rat, or rabbit isolated ventricular myocytes. Circ Res 72:194-205.
68. Smits P, Williams SB, Lipson DE, Bannit P, Rongen GA, Creager MA (1995): Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 92:2135-2141.
69. Stein B, Schmitz W, Schulz H, Seeland C (1994): Pharmacological characterization of A2-adenosine receptors in guinea-pig ventricular cardiomyocytes. J Mol Cell Cardiol 26:403-414.
70. Thames MD, Kinugawa T, Dibner-Dunlap ME (1993): Reflex sympathoexcitation by cardiac sympathetic afferents during myocardial ischemia. Role of adenosine. Circulation 87:1698-1704.
71. Thornton JD, Liu GS, Downey JM (1993): Pretreatment with pertussis toxin blocks the protective effects of preconditioning: Evidence for a C protein mechanism. J Mol Cell Cardiol 25:311-320.
72. Ueeda M, Thompson RD, Padgett WL, Secunda S, Daly JW, Olsson RA (1991): Cardiovascular actions of adenosines, but not adenosine receptors, differ in rat and guinea pig. Life Sci 49:1351-1358.
73. Vials A, Burnstock G (1992): Effects of nitric oxide synthase inhibitors, L-NG-nitroarginine and L-NG-nitroarginine methyl ester, on responses to vasodilators in the guinea-pig coronary vasculature. Br J Pharmacol 107:604-609.
74. Wahler CM, Dollinger SJ (1995): Nitric oxide donor SIN-1 inhibits mammalian calcium current through cGMP-dependent protein kinase. Am J Physiol 268:C45-C54.
75. Warren JB, Larkin SW, Kajekar R, Coughlin M, Williams TJ (1992): Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and edema potentiator in rabbit skin. Br J Pharmacol 106:331-334.
76. Warren JB, Wilson AJ, Loi RK, Goughlan ML (1993); Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J 7:1394-1400.
77. Watanabe H, Kuhne W, Spahr R, Schwartz P, Piper HM (1991): Macromolecule permeability of coronary and aortic endothelial monolayers under energy depletion. Am J Physiol 260:H1344-H1352.
78. Williams TJ (1982): Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and edema potentiator in rabbit skin. Br J Pharmacol 77:505-509.
79. Xu D, Kong H, Liang BT (1992): Expression and pharmacological characterization of a stimulatory subtype of adenosine receptor in fetal thick ventricular myocytes. Circ Res 70:56-65.
80. Yao Z, Gross GJ (1993a): Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism. Am J Physiol 264:H2221-H2225.
81. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration and infarct size in dogs. Circulation 89:1769-1775.
82. Zanzinger J, Bassenge E (1993): Coronary vasodilation to acetylcholine, adenosine and bradykinin in dogs: Effects of inhibition of NO synthesis and captopril. Eur Heart J 14(Suppl. 1):164-168.
83. 2 receptor through a protein kinase C signalling pathway. Circ Res 78:73-81.